<?xml-stylesheet type="text/xsl" href="./datadict_v2.xsl"?><data_table id="pht001739.v2" study_id="phs000285.v3" participant_set="2" date_created="Tue Aug 20 16:12:16 2013"><variable id="phv00117555.v2"><name>Individual_ID</name><description>Subject Identifier</description><type>string</type></variable><variable id="phv00117556.v2"><name>DLEFACT7</name><description>FACTOR VII (%)</description><type>integer</type><unit>%</unit><logical_min>5</logical_min><logical_max>191</logical_max></variable><variable id="phv00117557.v2"><name>DLEFACT8</name><description>FACTOR VIII (%)</description><type>integer</type><unit>%</unit><logical_min>22</logical_min><logical_max>310</logical_max></variable><variable id="phv00117558.v2"><name>DLEFIBR</name><description>FIBRINOGEN (MG/DL)</description><type>integer</type><unit>MG/DL</unit><logical_min>2</logical_min><logical_max>545</logical_max></variable><variable id="phv00117559.v2"><name>DLEVWANT</name><description>VON WILLEBRAND ANTIGEN (%)</description><type>integer</type><unit>%</unit><logical_min>28</logical_min><logical_max>395</logical_max></variable><variable id="phv00117560.v2"><name>DLEVWACT</name><description>VON WILLEBRAND ACTIVITY (%)</description><type>integer</type><unit>%</unit><logical_min>17</logical_min><logical_max>286</logical_max></variable><variable id="phv00117561.v2"><name>DLEBTYPE</name><description>ABO BLOOD TYPE</description><type>string</type></variable><variable id="phv00117562.v2"><name>DLELEWIS</name><description>LEWIS BLOOD GROUP PHENOTYPE</description><type>string</type></variable><variable id="phv00117563.v2"><name>DLEF7ANT</name><description>FACTOR VII ANTIGEN (%)</description><type>integer</type><unit>%</unit><logical_min>31</logical_min><logical_max>158</logical_max></variable></data_table>
